Pankaj Mistry

Pankaj Mistry

Johnson & Johnson Co. - New Jersey / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4388747
-
person_outline Pankaj Mistry's MOST POPULAR ARTICLES
1-) Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trialH Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ...The Lancet 393 (10166), 51-60, 20196832019
2-) Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agentsAD Cohen, MV Mateos, YC Cohen, P Rodriguez-Otero, B Paiva, ...Blood, The Journal of the American Society of Hematology 141 (3), 219-230, 2023482023
3-) Exercise versus usual care after non-reconstructive breast cancer surgery (UK PROSPER): multicentre randomised controlled trial and economic evaluationJ Bruce, B Mazuquin, A Canaway, A Hossain, E Williamson, P Mistry, ...bmj 375, 2021432021
4-) A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelinesP Mistry, JA Dunn, A MarshallBMC Medical Research Methodology 17, 1-9, 2017462017
5-) Management of hot flushes in UK breast cancer patients: clinician and patient perspectivesD Fenlon, A Morgan, P Khambaita, P Mistry, J Dunn, ML Ah-See, ...Journal of Psychosomatic Obstetrics & Gynecology 38 (4), 276-283, 2017252017